In 2020, embolic coiling procedures represented the largest share of cerebral aneurysm and AVM embolization procedures with a share of about three-quarters, followed by stent-assisted coiling, flow diversion and other novel/emerging embolization, and liquid embolization. In 2020, the combined global market for cerebral aneurysm and AVM embolization systems was estimated at $1.2bn.
Market drivers include the aging population, the advancement of screening techniques leading to increased diagnosis, advances in microsurgery, and new product introductions. This medical market and technology report provides a comprehensive discussion of the global market for neurointerventional cerebral aneurysm and AVM embolization systems.
This market comprises the following product segments: endovascular coils, liquid embolics, stents for stent-assisted coiling, flow diversion and flow disruption systems, and other novel/emerging embolization devices. Markets covered by this analysis comprise the US, Japan, the five major European markets (France, Germany, Italy, Spain, and the UK), and the rest of world (RoW) markets. The forecast range for this report is 2020-25.
